Interactive Exergaming With Otago Exercise Program on Mobility in Community-Dwelling Older Adults

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65-99
SponsorNational Taiwan University

About this trial

This clinical trial aims to evaluate the effectiveness of interactive exergaming combined with Otago Exercise Program on mobility among community-dwelling older adults aged 65 and above. The main research questions are:

Does this combined exercise intervention improve elderly mobility? Does this program enhance muscle strength and psychological well-being?

Researchers will compare two groups: one group will do the combined exercise program for 12 weeks, while the other group will continue their usual activities.

Participants will:

* Have their health checked three times: at the start, after 12 weeks, and 3 months later * If in the exercise group, attend exercise sessions twice a week for 12 weeks * Complete tests about their physical abilities and how they feel emotionally

Who can take part:

* Adults age 65 or older * People who need more than 12 seconds to stand up and sit down 5 times * People who can stand for at least 30 seconds with support

People cannot take part if they have serious vision problems, recent leg injuries, major illnesses, significant memory problems, or mental health conditions.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥ 65 years

Abnormal mobility based on ICOPE screening (Five-time chair stand test > 12 seconds)

Able to stand holding handrail for > 30 seconds

Disqualifiers

Severe visual impairment

Lower limb fracture

Acute serious illness

Moderate to severe cognitive impairment (SPMSQ > 5 errors)

Trial design

Design model

Parallel

Treatments tested in this trial

  • Interactive Exergaming with Otago Exercise Program

    Behavioral

    Participants will receive a 12-week structured program combining interactive exergaming and Otago Exercise Program. Sessions include balance training, strength exercises, and functional mobility activities delivered through interactive gaming platforms, supervised by trained instructors.

  • Control Group with Usual Care

    Other intervention

    Participants will maintain their regular activities at community centers or facilities, including cognitive therapy, oral exercises, and upper limb training programs, during the 12-week study period

Treatment groups

100 Participants
are divided into 2 treatment groups
Group A: Control Group with Usual CarePlacebo comparator 1 intervention
Group B: Interactive Exergaming with Otago Exercise ProgramExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Mobility Performance

Measured by Short Physical Performance Battery (SPPB) Scale: 0-12 points, higher scores indicate better performance

Time frame
Baseline, 12 weeks, 3 months
2

Lower Extremity Strength

Measured by digital dynamometer Unit: Kilograms (kg)

Time frame
Baseline, 12 weeks, 3 months

Secondary outcomes

1

Intrinsic Capacity Score

omprehensive assessment of intrinsic capacity using Integrated Care for Older People (ICOPE) screening tool, measuring six domains: * Cognition (3 memory items and orientation questions) * Mobility (5-time sit-to-stand test) * Nutrition (weight loss and appetite assessment) * Vision (visual assessment) * Hearing (whisper test) * Depression (mood and interest assessment) For each domain, if any item within that domain is abnormal, the domain is scored as 0 (indicating risk of capacity decline); if all items are normal, the domain is scored as 1 (normal). Total score ranges from 0 (all domains at risk) to 6 (all domains normal), with higher scores indicating fewer domains at risk of capacity decline.

Time frame
baseline (T0), post 12-week intervention (T1), and 3-month follow-up (T2)
2

Loneliness Level

Three-Item Loneliness Scale (T-ILS) Assessment of loneliness using T-ILS. Scale: 3-9 points, lower scores indicate less loneliness

Time frame
Measured at baseline (T0), post 12-week intervention (T1), and 3-month follow-up (T2)
3

Depression Symptoms

Assessment of depression symptoms using Geriatric Depression Scale-5 (GDS-5). Scale: 0-5 points, lower scores indicate less depressive symptoms

Time frame
Measured at baseline (T0), post 12-week intervention (T1), and 3-month follow-up (T2)
4

Well-being Status

Assessment of well-being using 9-item Well-being Scale. Scale: 9-45 points, higher scores indicate better well-being.

Time frame
Measured at baseline (T0), post 12-week intervention (T1), and 3-month follow-up (T2)

Other outcomes

Locations

1

Map coordinates are unavailable for these locations. Locations are shown below instead.

No. 105, Yusheng Street, Shilin District, Taipei City 111, Taiwan Status unavailable 111024, Taipei, TaipeiTaiwanTaiwan

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: